Cross-species transcriptomic analysis of mouse and rat lung exposed to chloroprene.
暂无分享,去创建一个
Melvin E. Andersen | Harvey J. Clewell | Michael B. Black | Russell S. Thomas | Eric Healy | M. Andersen | H. Clewell | Eric Healy | Yuching Yang | Yuching Yang | Matthew W. Himmelstein | M. Himmelstein
[1] W. P. Watson,et al. Identification of adducts derived from reactions of (1-chloroethenyl)oxirane with nucleosides and calf thymus DNA. , 2002, Chemical research in toxicology.
[2] W. P. Watson,et al. In vitro metabolism of chloroprene: species differences, epoxide stereochemistry and a de-chlorination pathway. , 2001, Chemical research in toxicology.
[3] S. C. Carpenter,et al. Kinetic modeling of beta-chloroprene metabolism: I. In vitro rates in liver and lung tissue fractions from mice, rats, hamsters, and humans. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[4] Russell S. Thomas,et al. Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[5] A. Visvikis,et al. The changing faces of glutathione, a cellular protagonist. , 2003, Biochemical pharmacology.
[6] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[7] R. J. Rowe,et al. DNA interstrand cross-linking activity of (1-Chloroethenyl)oxirane, a metabolite of beta-chloroprene. , 2010, Chemical research in toxicology.
[8] J. Trent,et al. Microarrays and toxicology: The advent of toxicogenomics , 1999, Molecular carcinogenesis.
[9] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[10] Michael B. Black,et al. Cross-species comparisons of transcriptomic alterations in human and rat primary hepatocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[11] Harvey J Clewell,et al. Kinetic modeling of β-chloroprene metabolism: Probabilistic in vitro-in vivo extrapolation of metabolism in the lung, liver and kidneys of mice, rats and humans. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.
[12] Elaina M Kenyon,et al. Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[13] J. Lynch. Occupational exposure to butadiene, isoprene and chloroprene. , 2001, Chemico-biological interactions.
[14] I. Pagan. Chloroprene: overview of studies under consideration for the development of an IRIS assessment. , 2007, Chemico-biological interactions.
[15] D. Posada,et al. Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. , 2004, Systematic biology.
[16] V. Feron,et al. Chronic inhalation toxicity and carcinogenicity studies on β-chloroprene in rats and hamsters , 1998 .
[17] W. P. Watson,et al. The metabolism and molecular toxicology of chloroprene. , 2007, Chemico-biological interactions.
[18] In vitro genotoxicity testing of (1-chloroethenyl)oxirane, a metabolite of beta-chloroprene. , 2001, Chemico-biological interactions.
[19] H J Clewell,et al. Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. , 2001, The Science of the total environment.
[20] Melvin E. Andersen,et al. Integrating pathway-based transcriptomic data into quantitative chemical risk assessment: a five chemical case study. , 2012, Mutation research.
[21] R Julian Preston,et al. Quantitation of molecular endpoints for the dose-response component of cancer risk assessment. , 2002, Toxicologic pathology.
[22] H. Akaike,et al. Information Theory and an Extension of the Maximum Likelihood Principle , 1973 .
[23] M. Andersen,et al. COMPARING RESPIRATORY-TRACT AND HEPATIC EXPOSURE-DOSE RELATIONSHIPS FOR METABOLIZED INHALED VAPORS: A PHARMACOKINETIC ANALYSIS , 2002, Inhalation toxicology.
[24] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[25] J. Bukowski. Epidemiologic Evidence for Chloroprene Carcinogenicity: Review of Study Quality and its Application to Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.
[26] S. C. Carpenter,et al. The metabolism of beta-chloroprene: preliminary in-vitro studies using liver microsomes. , 2001, Chemico-biological interactions.
[27] Harvey J Clewell,et al. A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.